Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells
Open Access
- 7 March 2007
- journal article
- Published by Springer Nature in Molecular Cancer
- Vol. 6 (1), 18
- https://doi.org/10.1186/1476-4598-6-18
Abstract
The expression level of osteopontin correlates with the metastatic potential of several tumors. Osteopontin is a well-characterized ligand for the αvβ3 integrin. The present study was undertaken to elucidate the possible role of osteopontin/αvβ3 signaling in prostate cancer cell migration.Keywords
This publication has 65 references indexed in Scilit:
- Expression Profile of RhoGTPases and RhoGEFs During RANKL-Stimulated Osteoclastogenesis: Identification of Essential Genes in OsteoclastsJournal of Bone and Mineral Research, 2006
- Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: Novel post-transcriptional, post-translational regulationClinical & Experimental Metastasis, 2005
- L’ostéopontine, une molécule aux multiples facettesmédecine/sciences, 2005
- Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cellsThe Prostate, 2003
- Molecular Mechanisms of Bone Metastasis and Therapeutic ImplicationsClinical Orthopaedics and Related Research, 2003
- Rho-dependent Rho Kinase Activation Increases CD44 Surface Expression and Bone Resorption in OsteoclastsPublished by Elsevier ,2003
- Osteoprotegerin differentially regulates protease expression in osteoclast culturesBiochemical and Biophysical Research Communications, 2002
- Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environmentThe Prostate, 1999
- De novo glomerular osteopontin expression in rat crescentic glomerulonephritisKidney International, 1998
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970